Lin Chu Tong

2011 9 -2019 7:, 2016 11 -2016 12:Gachon University Gil Hospital 2024 5: Global Executive Education Program 2019.08-2022.07:, 2022.08-:, (ASTS) (2023- ) (CSCO) (2025- ) (2023- ) (2024- ) (2025- ) (2024- ) 《 》 (2025- ) 《Science Progress》SCI (2025- ) 2024 10 —— 38: 2024 10 —— 62: 2024 9 ——2024: 2024 8 —— 2024 (WCLC 2024): 2024 5 —— 32 (ASCVTS2024):. 、,, 、,. ●,, —— 、,2026-01 2028-12,10,, ●,, 24Z10018, 、, 2024-07 2028-06, 150,, ●,, JKHY2023003, lncRNA HNF1A-AS1/ miR-30b ceRNA EIF5A2/β-catenin/TCF4, 2024-09 2025-12, 7.5,, ●, “ ”,TY2025007, CT,2025-01 2027-12,50,,SUBI ●,,BYSYRCYJ2023001,lncRNA HNF1A-AS1/miR-30b ceRNA EIF5A2/β-catenin/TCF4,2023-01 2025-12,50,, ●,,Y73481-01,,2022-01 2023-12,30,, 1.,,,. BRAF.. 2024:1-4. 2. Chen F#, Lin C #, Gu X, Ning Y, He H, Qiang G#. Exploring the link between walking and lung cancer risk: a two-stage Mendelian randomization analysis. BMC Pulm Med. Mar 13 2024;24(1):129. doi:10.1186/s12890-024-02906-0 (Q3, IF=3.2) 3. Yin H, Wang Z, Wang D, Nuer M, Han M, Ren P, Ma S, Lin C, Chen J, Xian H, Ai D, Li X, Ma S, Lin Z, Pan Y#. TIMELESS promotes the proliferation and migration of lung adenocarcinoma cells by activating EGFR through AMPK and SPHK1 regulation. Eur J Pharmacol. Jul 9 2023:175883. doi:10.1016/j.ejphar.2023.175883 (Q1, IF=5.0) 4. Chen Y#, Ma S#, Lin C, Zhu Z, Bai J, Yin Z, Sun Y, Mao F, Xue L, Ma S#. Integrative analysis of DNA methylomes reveals novel cell-free biomarkers in lung adenocarcinoma. Front Genet. 2023;14:1175784. doi:10.3389/fgene.2023.1175784 (Q2, IF=3.7) 5. Zhang L#, Lin C #, Liu Q, Gao J, Hou Y, Lin J#. Incidence and related risk factors of radiographic knee osteoarthritis: a population-based longitudinal study in China. J Orthop Surg Res. Jul 31 2021;16(1):474. doi:10.1186/s13018-021-02577-1 (Q2, IF=2.6) 6. Wang T, Zhang N, Fan S, Zhao L, Song W, Gong Y, Shen Q, Zhang C, Ren P, Lin C, Fu W, Gao GF, Ma S, Bi Y, Chen YG#. Establishment of human distal lung organoids for SARS-CoV-2 infection. Cell Discov. Nov 9 2021;7(1):108. doi:10.1038/s41421-021-00346-2 (Q1, IF=33.5) 7. Lin C, Hu F, Chu H, Ren P, Ma S, Wang J, Bai J, Han X, Ma S#. The role of EGFR-TKIs as adjuvant therapy in EGFR mutation-positive early-stage NSCLC: A meta-analysis. Thorac Cancer. Apr 2021;12(7):1084-1095. doi:10.1111/1759-7714.13874 (Q2, IF=2.9) 8. Hu F, Lin C, Chu H, Ren P, Wang J, Ma S#. Prognostic value of different N1 lymph node zones in pN1M0 non-small cell lung cancer: a systematic review and meta-analysis. Sci Rep. Nov 3 2021;11(1):21606. doi:10.1038/s41598-021-01136-2 (Q2, IF=4.2) 9. Cui J, Ren P, Li Y, Ma Y, Wang J, Lin C, Jing L, Tong X, Ma S#, Chen J#. ESRP1 as a prognostic factor of non-small-cell lung cancer is related to the EMT transcription factor of Twist. Thorac Cancer. Sep 2021;12(18):2449-2457. doi:10.1111/1759-7714.14088 (Q3, IF=2.9) 10. Zhang Q, Liu Q, Lin C, Baima Y, Li H, Gong H, Lin J#. The prevalence of rheumatoid arthritis in middle-aged and elderly people living in Naqu City, Tibet, Autonomous Region of China. J Orthop Surg Res. Aug 18 2020;15(1):338. doi:10.1186/s13018-020-01883-4 (Q2, IF=2.6) 11. Zhang Q, Gong H, Lin C, Liu Q, Baima Y, Wang Y, Lin J#. The prevalence of gout and hyperuricemia in middle-aged and elderly people in Tibet Autonomous Region, China: A preliminary study. Medicine (Baltimore). Jan 2020;99(2):e18542. doi:10.1097/MD.0000000000018542 (Q3, IF=1.6) 12. Long HB, Zeng XY, Liu Q, Wang HD, Vos T, Hou YF, Lin CT, Qiu YD, Wang K, Xing D, Zhang YQ, Zhou MG, Lin JH#. Burden of osteoarthritis in China, 1990-2017: findings from the Global Burden of Disease Study 2017. Lancet Rheumatology. Mar 2020;2(3):E164-E172. doi:10.1016/s2665-9913(19)30145-6 (Q1, IF=25.4) 13.,,,,,,,,,... 2019;34(05):511-516. 14. Qiu Y, Lin C, Liu Q, Zhong Q, Tao K, Xing D, Li H, Lin J#. Imaging features in incident radiographic patellofemoral osteoarthritis: the Beijing Shunyi osteoarthritis (BJS) study. BMC Musculoskelet Disord. Aug 7 2019;20(1):359. doi:10.1186/s12891-019-2730-x (Q2, IF=2.3) 1.,,,,,. [ ].,ZL 2024 1 0973680.9.: 2024 11 01 2.,,,,. [ ].,CN 119557840 B.:2025 01 26,:2025 03 04,:2025 05 27 3.,,,,,. [ ].,CN120154801B.:2025 04 07,:2025 06 17,:2025 08 26 [1],,, et al. 3D (2025 ) [J]., 2025, 32(05): 575-80. [2],,, et al. (2024 ) [J]., 2024, 31(12): 1703-12.